arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2602.01751cs.LGq-bio.QM

MGKAN:通过多模态图科拉莫戈洛夫-阿诺德网络预测非对称药物-药物相互作用

MGKAN: Predicting Asymmetric Drug-Drug Interactions via a Multimodal Graph Kolmogorov-Arnold Network

School of Mathematics, Shandong University, Jinan, China(山东大学数学学院);Data Science Institute, Shandong University, Jinan, China(山东大学数据科学研究院)

Kunyi Fan, Mengjie Chen, Longlong Li, Cunquan Qu

AI总结:

MGKAN通过多模态图科拉莫戈洛夫-阿诺德网络有效预测非对称药物-药物相互作用,提升建模的非线性和方向性。

摘要:

预测药物-药物相互作用(DDIs)对于安全的药理治疗至关重要。先前的图神经网络(GNN)模型利用分子结构和相互作用网络,但大多依赖线性聚合和对称假设,限制了其捕捉非线性和异质模式的能力。我们提出了MGKAN,一种图科拉莫戈洛夫-阿诺德网络,引入了可学习的基函数以进行非对称DDI预测。MGKAN用KAN驱动的基函数替代传统MLP转换,使药物关系的建模更具表现力和非线性。为捕捉药理依赖性,MGKAN整合了三种网络视角——非对称DDI网络、共相互作用网络和生化相似性网络,并通过角色特定嵌入来保留方向语义。融合模块结合线性注意力和非线性转换以增强表征能力。在两个基准数据集上,MGKAN优于七种最先进的基线。消融研究和案例研究证实了其预测准确性和在建模方向药物效应上的有效性。

英文摘要:

Predicting drug-drug interactions (DDIs) is essential for safe pharmacological treatments. Previous graph neural network (GNN) models leverage molecular structures and interaction networks but mostly rely on linear aggregation and symmetric assumptions, limiting their ability to capture nonlinear and heterogeneous patterns. We propose MGKAN, a Graph Kolmogorov-Arnold Network that introduces learnable basis functions into asymmetric DDI prediction. MGKAN replaces conventional MLP transformations with KAN-driven basis functions, enabling more expressive and nonlinear modeling of drug relationships. To capture pharmacological dependencies, MGKAN integrates three network views-an asymmetric DDI network, a co-interaction network, and a biochemical similarity network-with role-specific embeddings to preserve directional semantics. A fusion module combines linear attention and nonlinear transformation to enhance representational capacity. On two benchmark datasets, MGKAN outperforms seven state-of-the-art baselines. Ablation studies and case studies confirm its predictive accuracy and effectiveness in modeling directional drug effects.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑